In-Office Tympanostomy Tube Placement in Children (OTTER)
OTTER
OTTER
A Prospective, Single-arm, Multicenter Study to Evaluate Effectiveness and Safety of Tympanostomy Tube Placement Using the Tula Iontophoresis and Tube Delivery Systems for Children in an Office Setting.
Sponsor study identifier
interventional
370
2 countries
19
Study Start
October 31, 2017
Actual (reported)Primary Completion
February 28, 2019
Actual (reported)Study Completion
March 25, 2021
Actual (reported)A prospective, single-arm, multicenter study to evaluate effectiveness and safety of Tymbion iontophoresis and tympanostomy tube placement using the Tula Iontophoresis and Tube Delivery Systems for children in an office setting.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 25, 2021
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 24, 2017
Actual (reported)October 27, 2017
Actual (reported)October 31, 2017
Actual (reported)February 28, 2019
Actual (reported)January 31, 2020
Actual (reported)March 25, 2021
Actual (reported)Procedural Success:
Count (and percentage) of subjects in the pivotal cohort with successful placement of Tusker Medical tympanostomy tubes in all indicated ears in an office procedure. Note: the primary endpoint applies only to the Pivotal Cohort, and not to the OR Lead-In or Office Lead-In cohorts.
Day of Procedure (Day 0) Immediately following tube placement
Tube Placement Tolerability
Mean subject-reported pain score following TDS tube placement using the Faces Pain Scale-Revised (FPS-R) (pivotal cohort children ages 5 and older only). The FPS-R has 6 faces which permits scaling to a 0-to-10 scoring system in intervals of 2 (ie 0, 2, 4, 6, 8 and 10), where 0 represents 'no pain' and 10 represents 'very much pain'. Note- the primary endpoint applies only to the Pivotal Cohort, and not to the OR Lead-In or Office Lead-In cohorts.
Day of Procedure (Day 0) Immediately following tube placement
Tube Patency
3 Weeks Post Procedure
Tube Retention
3 Weeks Post Procedure
Anesthesia Effectiveness
Day of Procedure (Day 0)
Active Tymbion iontophoresis and tube insertion using the Tube Delivery System in-office.
Active Tymbion iontophoresis and tube insertion using the Tube Delivery System in-office. Physician initial in-office iontophoresis and tube insertion procedures (minimum of 2 subjects per investigator).
Tubes insertion using the Tube Delivery System in the operating room (OR). Physician initial tube insertion procedures in the OR (minimum of 2 subjects per investigator).
Subjects will receive active Tymbion iontophoresis and will have tubes placed in-office using the Tube Delivery System in all ears indicated for tube placement.
Subjects will have tubes placed in the OR using the Tube Delivery System in all ears indicated for tube placement.
California Head and Neck Specialists
Carlsbad, California, 92008, United States
Sacramento ENT
Roseville, California, 95661, United States
Camino Ear Nose & Throat Clinic
San Jose, California, 95138, United States
Connecticut Children's Medical Center
Hartford, Connecticut, 06106, United States
Yale School of Medicine, Section of Otolaryngology
New Haven, Connecticut, 06510, United States
South Florida Pediatric Otolaryngology
Fort Lauderdale, Florida, 33316, United States
Nemour's Children's Specialty Care
Lawrence Lustig
Columbia University
370 participants (actual enrollment reported by the registry).
First Submitted
October 24, 2017
First Posted
October 27, 2017
Study Start
October 31, 2017
Actual (reported)Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Jacksonville, Florida, 32207, United States
Advanced ENT & Allergy
Louisville, Kentucky, 40207, United States
Albany ENT & Allergy Services
Albany, New York, 12206, United States
Columbia University Medical Center
New York, New York, 10032, United States
Charlotte Ear Eye Nose & Throat Associates, PA
Charlotte, North Carolina, 28105, United States
Specialty Physician Associates
Bethlehem, Pennsylvania, 18017, United States
South Carolina Ear Nose and Throat
Lugoff, South Carolina, 29078, United States
Carolina Ear Nose and Throat Clinic
Orangeburg, South Carolina, 29118, United States
Ear Nose and Throat Specialists of Abilene
Abilene, Texas, 79601, United States
Frisco ENT for Children
Frisco, Texas, 75033, United States
Collin County ENT
Frisco, Texas, 75034, United States
Ear Medical Group
San Antonio, Texas, 78240, United States
British Columbia Children's Hospital
Vancouver, British Columbia, V6H 3N1, Canada
Primary Completion
February 28, 2019
Actual (reported)Study Completion
March 25, 2021
Actual (reported)Last Updated
May 26, 2022
Results First Posted
January 31, 2020
Record last verified: 2022-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: